Abvc Biopharma (ABVC) Revenue (2010 - 2025)
Abvc Biopharma's (ABVC) quarterly Revenue came in at -$764171.0 in Q4 2025, down 38969.33% YoY from N/an in Q4 2024, and down 38969.33% on a QoQ basis from $1966.0 in Q4 2024.
Abvc Biopharma (ABVC) Revenue (2010 - 2025) Analysis & Trends
Abvc Biopharma (ABVC) has 13 years of Revenue data on file, last reported at -$764171.0 in Q4 2025.
- Quarterly Revenue fell 38969.33% year-over-year to -$764171.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$255787.0 (down 150.19% YoY) and the FY2025 annual result came in at $31779.0, down 93.76% from the prior year.
- Revenue fell to -$764171.0 in Q4 2025, from $1966.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $588994.0 in Q4 2022 to a low of -$764171.0 in Q4 2025.
- A 5-year average of $51037.1 and a median of $31441.0 in 2021 frame the typical range for Revenue.
- Annual changes were most pronounced in 2024 — Revenue surged 2350.74% — and 2025, when it slumped 38969.33%.
- Tracing ABVC's Revenue over 5 years: stood at -$393589.5 in 2021, then jumped by 249.65% to $588994.0 in 2022, then plunged by 99.63% to $2165.0 in 2023, then fell by 9.19% to $1966.0 in 2024, then tumbled by 38969.33% to -$764171.0 in 2025.
- The last three Revenue figures came in at -$764171.0 (Q4 2025), $1966.0 (Q4 2024), and $389276.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Abvc Biopharma | 23.34 Mn | 23.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -764,171.00 |
| Dec 31, 2024 | 1,966.00 |
| Sep 30, 2024 | 389,276.00 |
| Jun 30, 2024 | 117,142.00 |
| Mar 31, 2024 | 1,205.00 |
| Dec 31, 2023 | 2,165.00 |
| Sep 30, 2023 | 15,884.00 |
| Jun 30, 2023 | 6,109.00 |
| Mar 31, 2023 | 128,272.00 |
| Dec 31, 2022 | 588,994.00 |
| Sep 30, 2022 | 42,269.00 |
| Jun 30, 2022 | 312,860.00 |
| Mar 31, 2022 | 25,660.00 |
| Dec 31, 2021 | -393,589.54 |
| Sep 30, 2021 | 98,999.00 |
| Jun 30, 2021 | 31,441.00 |
| Mar 31, 2021 | 263,150.00 |
| Dec 31, 2020 | 62,193.00 |
| Sep 30, 2020 | 115,553.00 |
| Jun 30, 2020 | 226,513.00 |